IXICO PLC has announced the appointment of Tanya Voloshen as its chief commercial officer, in a newly created role, as the firm seeks to accelerate business development activity and broaden its US footprint.
The AIM-listed neuroscience imaging and biomarker analytics group said Voloshen will be based in Boston, Massachusetts.
Voloshen joins the AIM-listed neuroscience imaging and biomarker analytics group from contract researcher Perceptive Inc, where she was as SVP of Commercial, and she previously held senior commercial leadership roles at neuroscience and medical imaging-focused companies, including Clario, QMENTA and ConcertAI.
"I am very pleased to welcome Tanya to IXICO as CCO, a newly appointed position in the senior leadership team that reflects a firm and continued commitment to strengthen our commercial capabilities and accelerate growth," said chief executive Bram Goorden.
"Based in Boston, Tanya brings strong commercial leadership experience, established customer relationships and an excellent understanding of the critical contribution that IXICO's technology platform can make in the clinical imaging market."